2-Ethylphenylhydrazine hydrochloride, 98.0%, 100g

3,6,9,12-Tetraoxatetradecan-1-ol, 14-amino-, 98%, 100mg

3-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95.0%, 250mg

4-(3-(Trimethoxysilyl)propyl)morpholine, 98.0%, 5g

METHYL 3-FORMYL-2-NITROBENZOATE, 95.0%, 25g

Thalidomide-O-C4-COOH, 500mg

Sodium 1-Octanesulfonate [for Biochemical Research]>98.0%(T)25g

[1,1':4',1'':4'',1'''-quaterphenyl]-4,4'''-dicarbaldehyde, 97%, 250mg

2-Methyl-1H-benzoimidazol-5-ylamine, 95.0%, 100g

éther tert-butylméthylique, min 99,5 %, pour la synthèse, 2,5 l, emballage en verre

(2,3-Difluorophenyl)thiourea, 97%, 1g

Polyethylene Glycol Monostearate (n=approx. 55) (palmitate and stearate mixture)25g

2-(2-Fluoro-3-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g